The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval ...

Please provide your email address to receive an email when new articles are posted on . A 71-year-old man was referred by his usual ophthalmologist to the neuro-ophthalmology clinic at Tufts Medical ...

Please provide your email address to receive an email when new articles are posted on . If approved, privosegtor would become the first neuroprotective therapy for optic neuropathies. The PIONEER 1 ...

To compare both retinal nerve fiber layer thickness and orbital color Doppler ultrasonography parameters in patients with multiple sclerosis (MS) versus healthy controls. The studied eyes exposed ...

Ophthalmologists, optometrists, and neurologists may be widely overdiagnosing optic neuritis, researchers say. Neuro-ophthalmologists at Washington University in St Louis, Missouri, could confirm only ...